BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22806902)

  • 1. The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer.
    Lee HJ; Jo DY
    Histol Histopathol; 2012 Sep; 27(9):1155-61. PubMed ID: 22806902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
    Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
    Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
    Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
    Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.
    Xue LJ; Mao XB; Ren LL; Chu XY
    Cancer Med; 2017 Jun; 6(6):1424-1436. PubMed ID: 28544785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
    Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
    Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer.
    Koizumi K; Kato S; Sakurai H; Hashimoto I; Yasumoto K; Saiki I
    Front Biosci (Schol Ed); 2012 Jan; 4(1):269-76. PubMed ID: 22202059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
    Mitchell B; Mahalingam M
    Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer.
    Masuda T; Nakashima Y; Ando K; Yoshinaga K; Saeki H; Oki E; Morita M; Oda Y; Maehara Y
    Anticancer Res; 2014 Nov; 34(11):6397-403. PubMed ID: 25368239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma.
    Ozawa PM; Ariza CB; Ishibashi CM; Fujita TC; Banin-Hirata BK; Oda JM; Watanabe MA
    Int J Cancer; 2016 Jan; 138(1):10-3. PubMed ID: 25400097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
    Mousavi A
    Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
    Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
    J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Zhou Y; Cao HB; Li WJ; Zhao L
    Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.
    Hinton CV; Avraham S; Avraham HK
    Clin Exp Metastasis; 2010 Feb; 27(2):97-105. PubMed ID: 18814042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
    Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of chemokine receptor CXCR4 in lung cancer.
    Gangadhar T; Nandi S; Salgia R
    Cancer Biol Ther; 2010 Mar; 9(6):409-16. PubMed ID: 20147779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune-mediated diseases.
    Britton C; Poznansky MC; Reeves P
    FASEB J; 2021 Apr; 35(4):e21260. PubMed ID: 33715207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C; Lei X; Xiong L; Hu Z; Tang B
    Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
    Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
    Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.